These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6403452)

  • 1. Immunofluorescence study of "non-idiopathic" renal amyloidosis.
    Orfila C; Rakotoarivony J; Segonds A; Suc JM
    Hum Pathol; 1983 Apr; 14(4):362-7. PubMed ID: 6403452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorescence study of childhood renal amyloidosis.
    Tinaztepe K; Güçer KS
    Turk J Pediatr; 1992; 34(1):5-14. PubMed ID: 1509531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
    Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
    Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerulonephropathy with amyloid-stain-negative microfibrillar glomerular deposits.
    Kobayashi Y; Fujii K; Kurokawa A; Kamiyama M; Miyazawa H
    Nephron; 1988; 48(1):33-9. PubMed ID: 3277075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunofluorescence characterization of light chains in human nephropathies.
    Orfila C; Rakotoarivony J; Manuel Y; Suc JM
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):591-4. PubMed ID: 3129870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light chain nephropathy: histological and clinical aspects in 15 cases.
    Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
    Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence findings in human renal amyloidosis.
    Jerath RS; Valenzuela R; Guerrero I; Deodhar SD; Vidt DB
    Am J Clin Pathol; 1980 Nov; 74(5):630-5. PubMed ID: 7004166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis.
    Alpers CE; Tu WH; Hopper J; Biava CG
    Hum Pathol; 1985 Mar; 16(3):294-304. PubMed ID: 3918930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologically-mediated renal disease in Waldenström's macroglobulinemia.
    Martelo OJ; Schultz DR; Pardo V; Perez-stable E
    Am J Med; 1975 Apr; 58(4):567-75. PubMed ID: 804814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic membranous glomerulonephritis associated with diabetes mellitus: light, immunofluorescence and electron microscopic study.
    Kobayashi K; Harada A; Onoyama K; Shimamatsu K; Maeda T; Fujimi S; Omae T
    Nephron; 1981; 28(4):163-8. PubMed ID: 7301001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association light chain deposition disease (LCDD) and amyloidosis. One case.
    Hofmann-Guilaine C; Nochy D; Jacquot C; Tricottet V; Bariety J; Camilleri JP
    Pathol Res Pract; 1985 Aug; 180(2):214-9. PubMed ID: 3932985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
    Noel LH; Droz D; Ganeval D; Grunfeld JP
    Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distinction between amyloidosis and fibrillar glomerulopathy.
    Casanova S; Donini U; Zucchelli P; Mazzucco G; Monga G; Linke RP
    Am J Clin Pathol; 1992 Jun; 97(6):787-95. PubMed ID: 1595598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillary renal deposits and nephritis.
    Duffy JL; Khurana E; Susin M; Gomez-Leon G; Churg J
    Am J Pathol; 1983 Dec; 113(3):279-90. PubMed ID: 6359891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin light chain amyloidosis and the kidney.
    Gertz MA; Lacy MQ; Dispenzieri A
    Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amyloidosis of juvenile rheumatoid arthritis - comparative studies in Polish and American children II. Serum immunoglobulins, kappa and lambda light chain and C3 levels.
    Filipowicz-Sosnowska AM; Baum J
    J Rheumatol; 1979; 6(3):277-85. PubMed ID: 114636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB; Tarantino A; Bazzi C; Colasanti G; Guerra L; Durante A
    Clin Nephrol; 1976 Jul; 6(1):303-10. PubMed ID: 782750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.